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The Kooyong Low Vision Clinic was established in Victoria, Australia in 1972 as a partnership between the University of Melbourne Department of Ophthalmology, the Association for the Blind and the Victorian College of Optometry. It was a pioneering site for multidisciplinary low vision rehabilitation, 1 and continues to provide tertiary care in the changing Australian rehabilitation landscape.
It has been over 15 years since the last published analysis of patient demographics at the Kooyong Low Vision Clinic. 2 Vision Australia's current multidisciplinary services include low vision clinics (optometry and orthoptics), library services, recreation services, technology advice and training, orientation and mobility training, social and emotional support and employment services. Optometry low vision clinic appointments are preceded by telephone intake, and usually followed by occupational therapy assessment. Occupational therapy clinic appointments include detailed needs assessment, discussion of other services, exploration of lighting, demonstration of adaptive techniques and technology, and onward referral for other rehabilitative services.
The Victorian population is growing and aging. Data from the Australian Bureau of Statistics indicate that in the past 15 years the number of Victorians has increased from approximately 4.7 million to 5.9 million, and the number aged over 40 years has increased from approximately 1.8 to 2.5 million. 3 Age-related eye diseases (particularly age related macular degeneration (AMD), glaucoma and diabetic retinopathy) are predominant cause of irreversible vision impairment. 4 The development and application of anti-Vascular Endothelial Growth Factor (anti-VEGF) agents has impacted the ability of ophthalmology to treat and manage patients with neovascular AMD. While landmark clinical trials including the MARINA study established that the anti-VEGF agent ranibizumab (Lucentis®, Novartis) can improve visual acuity, some 10% of patients will get worse and many (58%) will still have mild to moderate vision impairment (visual acuity below 6/12, i.e. below the driving standard) and could potentially derive much benefit from low vision intervention. 5 However, it is possible that patients may hold the mistaken belief that active anti-VEGF treatment renders rehabilitation unnecessary or inappropriate.
Advances in technology, increased availability and reduced cost of mainstream technology have had a flow-on effect into the assistive technology domain for people with vision impairment. 6 In particular, touch-screen technology and portable electronic devices (tablet computers and smart phones) with accessibility features for those with vision impairment are now widespread and more affordable.
It is likely that the aging population, development of new medical treatments and improved patient access to technology may impact both the demographic of Kooyong patients and the interventions prescribed. Updated data are required to facilitate planning and service delivery.
This study aimed to determine the basic demographic characteristics of Kooyong low vision clinic patients and prescribing patterns. this study to a previous study, the chi-square test was used.
Results
The sample comprised 155 new patients, of which 92 (59.3%) were female and 63 (40.7%) male. Median age at time of presentation was 84.3 years (range 7.7 to 98.1), with the predominant patient profile being a female aged in her 80s (27.1% of the cohort) ( Figure 1 ).
Analysis of basic demographic characteristics (Table 1) revealed that most patients lived either with a family member (47.1%) or alone (39.3%). Predominant causes of vision impairment were age-related (Table 2 ). Other/unspecified 12 (7.7)
Mean binocular peak contrast sensitivity (Melbourne Edge Test) was 13 dB (SD 4) among the 127 patients for whom this visual function was recorded. This represents a moderate reduction in contrast. Focal lighting evaluation was undertaken in 111 patients (71.6%), and was found to assist 104 (93.7%) of these patients. This brief evaluation involved demonstrating the use of a focal task light for reading and recording its effect on both the patient's subjective response and near visual acuity.
Spectacles were prescribed for 50 patients (Table 3) . Among the sample, 82 (52.9%) were already using some type of magnification device. Magnifiers were prescribed to 51 patients (Table 3) . Six patients were prescribed more than one magnifying device. A small number of anti-glare devices were prescribed (eight). In all age categories, hand-held magnifiers were the most popular magnification device. Interestingly, four out of five patients who were prescribed electronic devices were aged 60 years or older. Of the five patients prescribed an electronic device, all of which were portable, the BCVA varied from 0.40 logMAR (6/15) to 2.16 logMAR (6/750), with four of the five worse than 1.0 logMAR (6/60). One patient was also prescribed a 4x loupe, another was also prescribed a 7x pocket magnifier and another a maxTV 
Anti-Glare devices 8
Ninety-nine (63.9%) patients were referred to the occupational therapist following their optometry appointment. Twenty-two patients (14.2%) declined or did not require occupational therapy assistance, with the remainder of records incomplete on the matter. Sixteen patients (10.3%) were specifically referred for orientation and mobility assistance.
Discussion
The 'typical' Kooyong low vision clinic patient was an older adult female with AMD.
Kooyong patients in the older age bracket (60 years and over) tended to live at home either alone or with family, and were either self or family referred. Hand magnifiers were the most common low vision aid prescribed.
For the six-month period of this study, 155 new patients attended the Kooyong Low Vision
Clinic, compared to 295 in 1998 for the same period of time 2 . This is not an artefact of the retrospective nature of this study, but likely to reflect a reduction in sessions and patient numbers attending the Kooyong clinic. While this might in part be due to decentralised Vision Australia services in Victoria, it is unlikely to be the main reason. Unpublished ACO data for the time periods indicate that the number of patients attending Vision Australia for comprehensive assessment has declined throughout Victoria; with an 87.3% reduction at Kooyong, 59.2% reduction in metropolitan clinics and 28.3% reduction in regional clinics. There are some limitations of this study, primarily it being a retrospective clinical audit. Data for some variables were missing or incomplete, or may have been inaccurate.
Conclusions
There have been few changes in the presenting demographic and clinical findings of patients attending the Kooyong Low Vision Clinic over the last 16 years. This study has presented the characteristics of patients attending the Kooyong Low Vision Clinic. It has confirmed that although these patients still prefer traditional aids such as spectacles or simple magnifiers, they are becoming increasingly comfortable with technology and electronic vision enhancement devices. Future service planning predominantly aimed at retired patients, living at home with a moderate level of vision loss due to AMD, is required.
As a result of the aging Australian population and high proportion of age related disease in the low vision population, increased demand on low vision services is predicted for coming years. 9 However alongside this increase, the health funding landscape is become more restrictive. The challenge for the future will be to continue to provide timely, high quality low vision services to increased numbers of patients in an economically efficient model.
